Changes in Pediatric Acute Respiratory Infections Before, During, and After the COVID-19 Pandemic: A Retrospective

Ana Fradique1, Marta Rodrigues2, Laura Isabel Azevedo E Sousa3

  • 1Pediatrics, Unidade Local de Saúde de Coimbra, Coimbra, PRT.

Cureus
|October 23, 2025
PubMed

Insights

Non-pharmacological interventions (NPIs) during COVID-19 significantly reduced pediatric acute respiratory infections (ARIs). Post-pandemic, ARI incidence surged beyond pre-pandemic levels, though severity remained unchanged.

Area of Science:

  • Pediatric infectious diseases
  • Epidemiology
  • Public health

Background:

  • Acute respiratory infections (ARIs) are a major cause of childhood illness and emergency department visits.
  • Non-pharmacological interventions (NPIs) were implemented globally to curb SARS-CoV-2 transmission during the COVID-19 pandemic.
  • These NPIs impacted the circulation patterns of various respiratory pathogens in children.

Purpose of the Study:

  • To quantify the changes in incidence and severity of pediatric ARIs before, during, and after the COVID-19 pandemic.
  • To assess the impact of NPIs on the epidemiological trends of pediatric ARIs.

Main Methods:

  • Retrospective observational time-series study of children aged 0-10 years.
  • Data collected from a pediatric emergency department in Covilhã, Portugal, from April 2019 to April 2023.
  • Analysis of admissions from the first five days of each month, categorized into pre-COVID-19, COVID-19, and post-COVID-19 periods.

Main Results:

  • The proportion of ARI visits decreased during the COVID-19 period compared to pre-pandemic levels.
  • A significant increase in ARI incidence was observed in the post-COVID-19 period, exceeding pre-pandemic levels.
  • No significant variations were found in hospitalization rates, length of stay, or oxygen requirements.

Conclusions:

  • COVID-19 NPIs led to a notable reduction and altered seasonality of pediatric ARIs.
  • Following the lifting of restrictions, ARI incidence rose sharply, surpassing previous levels.
  • The findings underscore the influence of public health measures and exposure dynamics on pediatric respiratory infection epidemiology.
Abstract

Related Concept Videos

Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
832
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
451
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.0K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
768
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
723
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
3.0K